<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39500905</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Pulmonary diffusing capacity among individuals recovering from mild to moderate COVID-19: a cross-sectional study.</ArticleTitle><Pagination><StartPage>26767</StartPage><MedlinePgn>26767</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26767</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-74404-6</ELocationID><Abstract><AbstractText>Impaired pulmonary diffusing capacity for carbon monoxide (DLCO) following COVID-19 has been consistently reported among individuals recovering from severe-critical infection. However, most long COVID cases follow non-severe COVID-19. We assessed DLCO among individuals with long COVID recovering from mild to moderate acute illness. A cross-sectional study of adults with long COVID, assessed at a COVID recovery clinic&#x2009;&gt;&#x2009;3 months following the onset of acute infection, during 2020-2021. Participants subjectively ranked their dyspnea severity based on its impact on their daily living and underwent comprehensive pulmonary function testing (PFT). Clinical correlates for impaired DLCO (defined as &lt;&#x2009;80%) were assessed using multivariable logistic regression models. A total of 458 individuals, their mean age 45 (SD 16) and 246 (54%) of whom are women, were evaluated at an average of ~&#x2009;4 months following acute COVID-19. The most frequent PFT impairment was reduced DLCO, identified among 67 (17%) of the cohort. Clinical correlates of impaired DLCO included women (odds ration [OR] 3.64, 95% confidence interval [CI] 1.78-7.45, p&#x2009;&lt;&#x2009;0.001), cigarette smoking (OR 2.25, 95% CI 1.14-4.43, p&#x2009;=&#x2009;0.019), and moderate-severe dyspnea (OR 2.77, 95% CI 1.39-5.50, p&#x2009;=&#x2009;0.004). BMI inversely correlated with DLCO (OR 0.90, 95% CI 0.85-0.96 per 1 unit, p&#x2009;=&#x2009;0.002). Impaired DLCO was not uncommon among individuals recovering from mild to moderate COVID-19. Women are at a greater risk, and subjective dyspnea correlated with impaired DLCO. Clinicians can rely on self-reported significant dyspnea to guide further assessment.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yelin</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Sheba Medical Center, Ramat Gan, Israel. dana.yelin@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel. dana.yelin@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghantous</LastName><ForeName>Nassem</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awwad</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daitch</LastName><ForeName>Vered</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research Authority, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalfon</LastName><ForeName>Talya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mor</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchrits</LastName><ForeName>Shira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine A, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafir</LastName><ForeName>Yair</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine F, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapira-Lichter</LastName><ForeName>Irit</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Functional MRI Center, Sagol School of Neuroscience, Rabin Medical Center, Beilinson Hospital, Tel Aviv University, Petah Tikva, Ramat Aviv, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leibovici</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Authority, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yahav</LastName><ForeName>Dafna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Sheba Medical Center, Ramat Gan, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margalit</LastName><ForeName>Ili</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Sheba Medical Center, Ramat Gan, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shitenberg</LastName><ForeName>Dorit</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pulmonary Institue, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rabin Medical Center, COVID Recovery Clinic, Beilinson Hospital, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011653" MajorTopicYN="Y">Pulmonary Diffusing Capacity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">Pulmonary function testing</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>6</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>6</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39500905</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-74404-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-74404-6</ArticleId><ArticleId IdType="pmc">PMC11538246</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Michelen, M. et al. Characterising long COVID: A living systematic review. BMJ Glob Health. 6(9), e005427 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin, D. et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin. Microbiol. Infect.28(7), 955&#x2013;972 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenoir, A. et al. Pulmonary recovery 12 months after non-severe and severe COVID-19: The prospective Swiss COVID-19 lung study. Respiration. 102(2), 120&#x2013;133 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932828</ArticleId><ArticleId IdType="pubmed">36566741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rsell, T. et al. Risk factors for impaired respiratory function post COVID-19: A prospective cohort study of nonhospitalized and hospitalized patients. J. Intern. Med.293(5), 600&#x2013;614 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36815689</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna, A. et al. The role of pulmonary function testing and lung imaging in the Long-Term Follow-Up of patients with COVID-19 pneumonia role of pulmonary function tests and high-resolution computed tomography in Post-COVID-19 interstitial lung disease. Respiration. 102(4), 287&#x2013;295 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9981778</ArticleId><ArticleId IdType="pubmed">36806049</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook, H., Raza, S., Nowell, J., Young, M. &amp; Edison, P. Long covid-mechanisms, risk factors, and management. BMJ. 374, n1648 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Malesevic, S. et al. Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19. Sci. Rep.13(1), 7717 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10175927</ArticleId><ArticleId IdType="pubmed">37173355</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Clinical management of COVID-19. April (2023). https://www.who.int/teams/health-care-readiness/covid-19. Accessed.</Citation></Reference><Reference><Citation>Culver, B. H. et al. Recommendations for a standardized pulmonary function report. An Official American Thoracic Society Technical Statement. Am. J. Respir Crit. Care Med.196(11), 1463&#x2013;1472 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29192835</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, X. et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir Med.9(7), 747&#x2013;754 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;i, E. E. R. F. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir Med.182, 106394 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047337</ArticleId><ArticleId IdType="pubmed">33901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure, A. et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir Med.181, 106383 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi, S. et al. Long term impact on lung function of patients with moderate and severe COVID-19. A prospective cohort study. Front. Public. Health. 9, 663076 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8688692</ArticleId><ArticleId IdType="pubmed">34950621</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso, M. J. et al. Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. Sci. Transl Med.16(754), eadk3295 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11337933</ArticleId><ArticleId IdType="pubmed">38959327</ArticleId></ArticleIdList></Reference><Reference><Citation>Riou, M. et al. Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A review. Int. J. Mol. Sci.25(9), 4941 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11084496</ArticleId><ArticleId IdType="pubmed">38732160</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L. et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 398(10302), 747&#x2013;758 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L. et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study. Lancet Respir Med.10(9), 863&#x2013;876 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, F. et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin Microbiol Infect. 28(4), 611.e9-611.e16. (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz, D. A. et al. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am. Rev. Respir Dis.144(3 Pt 1), 504&#x2013;506 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1892287</ArticleId></ArticleIdList></Reference><Reference><Citation>Holley, A. B. et al. Obesity-related changes in diffusing capacity and transfer coefficient of the lung for Carbon Monoxide and resulting patterns of abnormality across reference equations. Ann. Am. Thorac. Soc.20(7), 969&#x2013;975 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36763964</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, R. L. &amp; Nzekwu, M. M. U. The effects of body mass index on lung volumes. Chest. 130(3), 827&#x2013;833 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16963682</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>